β-Arrestin 2 knockout mice exhibit sensitized dopamine release and increased reward in response to a low dose of alcohol

Psychopharmacology

Volumn 230, Issue 3, 2013, Pages 439-449

  Björk, Karl ^a,c,f   Tronci, Valeria ^b   Thorsell, Annika ^c,d   Tanda, Gianluigi ^b   Hirth, Natalie ^e   Heilig, Markus ^c   Hansson, Anita C ^c,e   Sommer, Wolfgang H ^c,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d LINKÖPING UNIVERSITY   (Sweden)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alcohol; Arrestin; Dopamine; Nucleus accumbens; Opioid; Reward

Indexed keywords

ALCOHOL; BETA ARRESTIN 2; DOPAMINE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARRB2 GENE; ARTICLE; AUTORADIOGRAPHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; DOPAMINE RELEASE; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; REWARD;

AMYGDALA; ANIMALS; ARRESTINS; AUTORADIOGRAPHY; CONDITIONING (PSYCHOLOGY); CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; MICE; MICE, KNOCKOUT; MICRODIALYSIS; NUCLEUS ACCUMBENS; RECEPTORS, OPIOID, MU; REWARD;

EID: 84888636180     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3166-x     Document Type: Article

References (43)

1. Acquas E, Tanda G et al (2002) Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats. Neuropsychopharmacology 27(2):182-193
2. Arias A, Feinn R et al (2006) Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. Drug Alcohol Depend 83(3):262-268
3. Arlinde C, Sommer W et al (2004) A cluster of differentially expressed signal transduction genes identified by microarray analysis in a rat genetic model of alcoholism. Pharmacogenomics J 4(3):208-218
4. Bjork K, Svenningsson P (2011) Modulation of monoamine receptors by adaptor proteins and lipid rafts: role in some effects of centrally acting drugs and therapeutic agents. Annu Rev Pharmacol Toxicol 51:211-242
5. Bjork K, Rimondini R et al (2008) Modulation of voluntary ethanol consumption by beta-arrestin 2. FASEB J 22(7):2552-2560
6. Bockaert J, Perroy J et al (2010) GPCR interacting proteins (GIPs) in the nervous system: Roles in physiology and pathologies. Annu Rev Pharmacol Toxicol 50:89-109
7. Bohn LM, Lefkowitz RJ et al (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286(5449):2495-2498
8. Bohn LM, Gainetdinov RR et al (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408(6813):720-723
9. Bohn LM, Gainetdinov RR et al (2003) Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. J Neurosci 23(32):10265-10273
10. Chamorro AJ, Marcos M et al (2012) Association of micro-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis. Addict Biol 17(3):505-512
11. Colasanti, A., G. E. Searle, et al. (2012). Endogenous opioid release in the human brain reward system induced by acute amphetamine administration. Biol Psychiatry
12. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85(14):5274-5278
13. Di Chiara G, Acquas E et al (1996) Ethanol as a neurochemical surrogate of conventional reinforcers: the dopamine-opioid link. Alcohol 13(1):13-17
14. Franklin KM, Engleman EA et al (2009) A single, moderate ethanol exposure alters extracellular dopamine levels and dopamine d receptor function in the nucleus accumbens of wistar rats. Alcohol Clin Exp Res 33(10):1721-1730
15. Heilig M, Goldman D et al (2011) Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci 12(11):670-684
16. Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12(2):483-488
17. Kranzler, H. R., S. Armeli, et al. (2012). Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment. Addict Biol
18. Loland CJ, Mereu M et al (2012) R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse. Biol Psychiatry 72(5):405-413
19. Mahler SV, Berridge KC (2009) Which cue to "want?" Central amygdala opioid activation enhances and focuses incentive salience on a prepotent reward cue. J Neurosci 29(20):6500-6513
20. Mahler SV, Berridge KC (2012) What and when to "want"? Amygdala-based focusing of incentive salience upon sugar and sex. Psychopharmacology (Berl) 221(3):407-426
21. Mitchell JM, O'Neil JP et al (2012) Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens. Sci Transl Med 4(116):116ra116
22. Oneda B, Preisig M et al (2010) Lack of association between genetic polymorphisms of ARRB2 and alcohol dependence in a Caucasian population. Alcohol Alcohol 45(6):590-591
23. Oslin DW, Berrettini W et al (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28(8):1546-1552
24. Paxinos G, Franklin KBJ (2004) The mouse brain in stereotaxic coordinates. Elsevier Academic, Amsterdam
25. Ramchandani VA, Umhau J et al (2011) A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry 16(8):809-817
26. Ray LA, Hutchison KE (2007) Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry 64(9):1069-1077
27. Robinson TE, Berridge KC (2003) Addiction. Annu Rev Psychol 54:25-53
28. Ron D, Messing RO (2013) Signaling pathways mediating alcohol effects. Curr Top Behav Neurosci 13:87-126
29. Schmid CL, Bohn LM (2009) Physiological and pharmacological implications of beta-arrestin regulation. Pharmacol Ther 121(3):285-293
30. Shenoy SK, Lefkowitz RJ (2005) Seven-transmembrane receptor signaling through beta-arrestin. Sci STKE 2005(308):cm10
31. Simmons D, Self DW (2009) Role of mu- and delta-opioid receptors in the nucleus accumbens in cocaine-seeking behavior. Neuropsychopharmacology 34(8):1946-1957
32. Skinbjerg M, Ariano MA et al (2009) Arrestin3 mediates D(2) dopamine receptor internalization. Synapse 63(7):621-624
33. Smith KS, Berridge KC (2007) Opioid limbic circuit for reward: interaction between hedonic hotspots of nucleus accumbens and ventral pallidum. J Neurosci 27(7):1594-1605
34. Smith KS, Tindell AJ et al (2009) Ventral pallidum roles in reward and motivation. Behav Brain Res 196(2):155-167
35. Spanagel R (2009) Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev 89(2):649-705
36. Spanagel R, Herz A et al (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A 89(6):2046-2050
37. Tanda G, Di Chiara G (1998) A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse. Eur J Neurosci 10(3):1179-1187
38. Tanda G, Newman AH et al (2009) Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity. J Pharmacol Exp Ther 330(3):802-809
39. Thorsell A, Schank JR et al (2010) Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice. Psychopharmacology (Berl) 209(1):103-111
40. Tzschentke TM (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12(3-4):227-462
41. Vaccarino FJ, Amalric M et al (1986) Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat. Pharmacol Biochem Behav 24(1):61-65
42. Wassum KM, Ostlund SB et al (2009) Distinct opioid circuits determine the palatability and the desirability of rewarding events. Proc Natl Acad Sci U S A 106(30):12512-12517
43. Wassum KM, Cely IC et al (2011) Micro-opioid receptor activation in the basolateral amygdala mediates the learning of increases but not decreases in the incentive value of a food reward. J Neurosci 31(5):1591-1599